Ideal pain relief for musculoskeletal injury remains elusiveA comparison of a combination of oral morphine and oral ibuprofen with each of these drugs alone found that none of these options provided optimal analgesia for the pain of a musculoskeletal injury (MSK-I).
Study: Formularies may be key to alleviating opioid epidemicNew Yale University research offers stunning findings about drug formulary coverage and prescribing opioids.
High-Alert Medications
High-Alert MedicationsHigh-alert drugs pose a significant threat to patient safety. There are safeguards that pharmacists should put in place to reduce the risk.
DEA wants to slash opioid productionThe Drug Enforcement Administration wants to slash the production of opioid painkillers by 20% in 2018.
Four developments helping address the opioid epidemicAs the opioid epidemic continues across the U.S., new treatment programs and guidelines could help reverse the trend.
Opioid use for chronic pain: The debate goes onA champion of pain patients and a proponent of limited opioid access talk about the issues in a genial debate.
New HHS plan on opioids ups naloxone useHealth and Human Services (HHS) recently launched a widespread initiative – including increasing the use of naloxone to reverse opioid overdoses – aimed at reducing prescription opioid and heroin related overdose, death and dependence.
Higher opioid doses linked to increase in depression: StudyPatients who increased doses of opioid medicines to manage chronic pain were more likely to experience an increase in depression, according to a study published in the February issue of Pain.
FDA defers to docs in use of pain therapies for pregnant womenIn a drug safety communication, FDA said that it is aware of recent reports questioning the safety of prescription and over-the-counter (OTC) pain drugs when used during pregnancy, but that it lacks adequate studies to change current recommendations.
[BLOG]: Cost containment through the use of generic medicationsThere’s no hiding that hospital pharmacies have long been considered cost centers for healthcare systems. That positioning has been accentuated over the past 5 years, as the healthcare industry has seen a steady increase in high-cost, brand-name specialty medications that range from hundreds to thousands, sometimes tens of thousands, of dollars per dose. Nearly every hospital, however, has untapped opportunities to substantially improve efficiencies and improve costs. One important factor is improving how these hospitals use generic medications.